Clinical Trial Update: A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for a study of durvalumab and monalizumab in advanced solid tumors (Phase 1/2). The trial is currently active but not recruiting, with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Durvalumab (durvalumab)
• Monalizumab (monalizumab)

Snippet

Sponsor: MedImmune LLC | Conditions: Advanced Solid Tumors | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-03-09